tubes were pooled together and purified using Agencount AMPure XP system. The amplicon library was eluted in 44 µl of EB.
Library Preparation End Repair
The 5' ends of the PCR products were phosphorylated using T4 Polynucleotide Kinase (PNK) enzyme (NEB) in the presence of T4 DNA Ligase buffer containing ATP. The T4 PNK treatment was set up as follows: Amplicon library: 44 µl T4 DNA ligase buffer: 5 µl T4 PNK: 1 µl (10 units) The reaction was incubated at 37°C for 30 mins. Later, the reaction was purified using Agencourt AMPure XP system and eluted in 15 µl of EB.
Ligation
Custom adaptor oligos were ordered in 100 µM concentration (Valuegene Inc.) with following modifications: a) Adaptor_A_F Adaptor oligos referring to adaptor A (a, b) and adaptor B (c, d) were mixed in equi-molar concentrations and diluted to 2 µM final concentration. Both adaptors were later denatured at 95°C for 5 mins and then brought back to room temperature gradually at -0.2°C/s. This allowed hybridization of the two oligos of the adaptor with 'T' overhang. The adaptor mix was further diluted 1:10 to get a stock concentration of 200 nM. The Ligation reaction was set up as follows: T4 PNK treated PCR product: 6 µl Adapter A: 1 µl Adapter B: 1 µl T4 DNA Ligase Buffer: 1 µl T4 DNA Ligase (NEB): 1 µl (400 units) The reaction was performed at room temperature for 1 hr or at 16 °C overnight.
Selection of adaptor orientation
Ligation reaction resulted in fragments with either two identical (A-A and B-B) or two distinct (A-B and B-A) adapter orientations. However, only distinct adapter orientation fragments can be sequenced in Illumina's platform. We enriched desired ligation products by utilizing the biotin (adaptor A) -streptavidin chemistry. Streptavidin coated magnetic beads (Dynabeads MyOne Streptavidin C1, Invitrogen) were used to pull down A-A, A-B and B-A ligation products using manufacturer's protocol. The supernatant, containing B-B, was discarded. Later, 0.2 N NaOH was added to the beads. Incubation for 10 mins at room temperature denatured two strands of the ligation product. Only A'-B strand appeared in the supernatant while both strands of the A-A remained associated with the beads. The supernatant with distinct orientation was extracted and column purified using MinElute PCR Cleanup Kit (Qiagen). The pH of the supernatant was adjusted to allow maximal binding to the column. The single stranded DNA was eluted in 36 µl of EB.
Final PCR and size selection
The single stranded DNA obtained from previous step was amplified using adaptor specific primers. Following primers were ordered in 100 uM concentration: a) Final_FP:
A 50 µl PCR reaction was set up with 18 µl of single stranded template, 5 µl of primers (2 µM stock), 4% DMSO, 5 µl Pfu Turbo reaction buffer (10X), 0.2 mM dNTP (10 mM stock), 2.5 units of Pfu Turbo Polymerase. The amplification consisted of 14 cycles of denaturation (95°C -30s), annealing (62°C -30s) and extension (72°C -40 s).
The amplified product was run in 2% agarose gel at 80 -100 volts for 1 hr. Using 50 bp ladder (NEB) a band corresponding to size range of 150 -500 bp was cut out. The DNA was retrieved from the gel using MinElute Gel Extraction Kit (Qiagen) with 15 µl of elution.
Quantification of the sequencing library Quantitative real time PCR was used to determine the concentration of the sequencing libraries prepared by our protocol. The standard curve for various dilutions of phiX control library was generated using the adapter specific primers recommended by Illumina. We later used the standard curve to determine the molarity of our sequencing libraries.
The concentration of sequencing library loaded into the flowcell was calibrated by the sequencing facility. We typically obtained good cluster density with 5 pM of library concentration on HiSeq v3 kit.
Oligonucleotides
All of our heptamer primers were flanked by universal adapter sequence (5'-CCGAATA-heptamer-3') and synthesized by Valuegene Inc. These primers were desalted and suspended in RNase/DNase free water to 100 µM concentration.
Later, the primers were pooled together into three different tubes as described in Supplementary Table S4 at equi-molar concentration to prepare a stock solution containing 2 µM of each heptamer primer.
Mouse embryonic stem cell culture and differentiation
Mouse R1 or T-GFP embryonic stem cells were cultured on mouse embryonic fibroblast (MEF) on gelatin-coated dishes in high glucose DMEM (Hyclone, Logan, UT) supplemented with 10% fetal calf serum (FCS) (Hyclone, Logan, UT), 0.1 mM b-mercaptoethanol (GIBCO), 1% non-essential amino acids (GIBCO), 2 mM L-glutamine (Sigma, St. Louis, MO), sodium pyruvate (Sigma), antibiotics (Sigma), and 1,000 U/ml of LIF (Sigma) and passaged with 0.25% Trypsin (GIBCO).
For embryoid body (EB) differentiation, MEF were stripped from the cultures by 15 minutes incubations on gelatin-coated dishes. mESCs were collected and washed in PBS to remove traces of serum. mESCs were differentiated in serum free media containing N2 and B27 supplements as described elsewhere 2, 3 . mESCs were aggregated at 50,000 cells/ml in non-coated polystyrene plates. After 2 days, EBs were dissociated by trypsin treatment and re-aggregated in fresh media in presence of different growth factors and small molecules. Activin A and BMP4 were obtained from R&D Systems while SB-431542 was obtained from Sigma. IWR-1 was synthesized in house as described previously 4 . EBs were harvested at day 4 for RNA extraction and processing.
Library Generation for mRNA dilution series using DP-seq Serial dilutions (10 ng, 1 ng, 100 pg, 50 pg, 10 pg, and 1 pg) were prepared for the mRNA derived from Activin A (3 ng/mL) sample. First strand cDNA synthesis was performed for all mRNA dilutions in duplicates to get the technical replicates. Later, the purified cDNA prepared from each dilution, was split into three tubes to perform amplification using our heptamer primers. The numbers of PCR cycles were increased for lower dilutions to get appropriate amounts of DNA for the library construction. The numbers of PCR cycles used are as follows: 10 ng and 1 ng -13 cycles 100 pg and 50 pg -16 cycles 10 pg -19 cycles 1 pg -23 cycles The amplicon libraries thus constructed, were phosphorylated at the 5' end as mentioned above. Later, the libraries were ligated with Illumina's Y-adaptors and amplified using adaptor specific primers consisting of a different Illumina's Truseq barcode sequence for each library. The amplified libraries were run through the 2% agarose gel and size selected (150 -500 bp) for sequencing. Similar methodology was used for the generation of sequencing libraries with ribosomal inhibition primers.
Library Generation using Std. RNA-seq protocol
Std. RNA-seq 5 libraries were constructed from about 10 ng of mRNA derived from Activin A (3 ng/mL) and Activin A (100 ng/mL) samples using Illumina's TruSeq RNA Sample Prep Kit v2.
Library Generation using Smart-seq Smart-Seq cDNA generation and amplification was performed on 50 picograms of mRNA derived from Activin A (3 ng/mL and 100 ng/mL) treated samples using SMARTer Ultra Low RNA Kit for Illumina sequencing (Clontech). We performed 13 cycles of amplification to achieve about 1-10 ng of the amplified cDNA libraries. These libraries were later sheared using Covaris system to obtain 200-500 bp fragments. Later, standard Illumina library preparation protocol was followed to prepare the sequencing libraries using Illumina Paired-End DNA Sample Prep kit.
Reverse Transcription and Quantitative RT-PCR (qPCR)
Total RNA was extracted from cells using Trizol (Invitrogen) according to the manufacturer's instructions. About 1 µg of total RNA was treated for DNA removal and converted into first strand cDNA using Quantitect Reverse Transcription kit (Qiagen). SYBR Green qPCR was run on a LightCycler 480 (Roche) using the LightCycler 480 SYBR Green Master Kit (Roche). All primers were designed with a T m of 60°C. Data was analyzed using the ΔΔC t method, using β-actin as normalization control, which was determined as a valid reference in mouse ESC differentiation. The primer sequences are listed in Supplementary Table S6 .
Flow Cytometry
Day 4 embryoid bodies from T-GFP mESC were dissociated with trypsin to single cell suspensions and analyzed on a FACSCanto (BD Biosciences). Prior to analysis, cells were stained with propidium iodide to label dead cells. Data analysis was performed using FlowJo (Treestar Inc.) where measured events were gated for PI negative populations (exclusion of dead cells) and forward/side scatter (exclusion of debris and aggregates) before generating dot plots.
Data Analysis

Mapping reads
Our libraries were sequenced on Illumina's GIIx Analyzer and HISEQ2000 platforms. We performed single end 36 sequencing cycles on version 5.0 of flowcell (FC-104-5001 | TruSeq SBS Kit v5 -GA (36-cycle)). The raw reads were truncated as 32-mer with the first and last 2 base pairs of the reads removed. The 32-mer reads were aligned to the RefSeq mRNA database allowing up to 2 mismatches using our in-house software which uses suffix array implementation. Reads that did not align to the mouse RefSeq mRNA database were later aligned to mouse genome using Bowtie 6 . Libraries constructed from serial dilutions of mRNA were sequenced in Illumina's HiSeq2000 systems (TruSeq SR Cluster Kit v3-cBot-HS and TruSeq SBS Kit v3-HS). The libraries were sequenced as 100 bp single-end reads. The first 14 sequences came from our heptamer primers including the universal tail sequence (5'-CCGAATA-3') as such the first 14 bps were truncated and next 32 bp sequence was aligned to the mouse transcriptome allowing ≤ 2 mismatches.
Mapping of Smart-seq reads
The number of reads obtained from Smart-seq was double the number of reads for DP-seq. Previous studies 7, 8 have demonstrated that the transcriptome coverage and the technical noise in expression measurements vary with the sequencing depth and global normalization of the reads across different samples is heavily affected by few highly expressing transcripts. In order to perform an objective comparison between Smart-seq and DP-seq, we downsized the Smartseq libraries by generating multiple random sets, consisting of a similar number of reads obtained from DP-seq. The reads in these datasets were mapped to the mouse transcriptome allowing ≤ 2 mismatches. The analysis of these random sets showed similar transcriptome coverage and technical noise. The table below summarizes the results obtained for the three different random sets generated from Activin A 100 ng/mL dosage. The First two columns depict the entire dataset. In this study, we present the comparison of DP-seq with one of the random sets (random set 1) generated from the Smart-seq library.
Differential gene expression analysis
We employed a local pooled variance test similar to LPE 9 to identify differentially regulated transcripts. For each transcript, unique reads coming from predicted and non-predicted primer-binding sites were combined in all samples. Prior to identifying the differentially expressed transcripts, the fold changes between control and treatment conditions (including technical replicates) were lowess normalized to eliminate average read dependent variations in the fold changes. The noise in the technical replicates reflected variability arising out of sample preparation and the sequencing platform. As such we used the expression measurements obtained from the technical replicates to determine the baseline (null) distribution where no differential expression of the transcripts was expected. The null distribution was determined by plotting M and A quantities for technical replicates, which are defined as:
where 'i' and 'j' represents any two samples. M corresponds to log ratio in unique reads for a transcript between samples 'i' and 'j' while A corresponds to average reads for the transcript in the two samples.
To quantify the technical noise, we pooled the expression of ~200 transcripts in the null distribution with similar reads and estimated the standard deviation in their fold change. We assumed that all transcripts with similar expression measurements possess similar noise. Also, the distribution of the fold changes was assumed to follow a Gaussian distribution. Next, a threshold for differentially expressed transcripts was determined as 1.96 times the standard deviation, corresponding to a less than 5% chance of the transcript being called differentially expressed by random chance. The experimental MA plot, which was defined as treatment/control, was overlaid on the technical replicate MA plot and any transcript representing a fold change above/below the threshold was designated as differentially expressed. Higher thresholds (blue curve) were used for the low expressing transcripts as demonstrated in Supplementary Fig. S12 .
Identification of Activin A/TGFβ target genes
Putative Activin A/TGFβ target genes were determined as genes exhibiting opposite mode of regulation in AA3 and SB samples as compared to serum free media control. The target genes were further classified into three categories of expression as shown below:
A p-value cutoff of 0.05 was used to determine differentially expressed transcripts. Table S1B : Mapping summary of sequencing libraries made from different protocols using two different dosages of Activin A 3ng/mL (AA3) and 100ng/mL (AA100). Smart--seq mapping summary is given for one of the random sets obtained from all of the reads. Ribosome inhibition libraries were made from Activin A (3ng/mL; AA3) sample using DP--seq. Table S2 : GO (Biological Process) Enrichment for genes differentially regulated in SB/AA15. Genes up--regulated in SB are enriched for ectoderm related terms while genes up--regulated in AA15 are enriched for mesoderm and endoderm related terms. P--values were determined from background set of genes that showed expression in SB/AA15 samples. 
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